* Inogen Inc reported a quarterly adjusted loss of 25 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -55 cents. The mean expectation of four analysts for the quarter was for a loss of 49 cents per share. Wall Street expected results to range from -62 cents to -42 cents per share.
* Revenue rose 5.8% to $88.83 million from a year ago; analysts expected $84.14 million.
* Inogen Inc's reported EPS for the quarter was a loss of 25 cents.
* The company reported a quarterly loss of $5.96 million.
* Inogen Inc shares had fallen by 2.5% this quarter and gained 72.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in the last three months.
* In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Inogen Inc is 10.00 This summary was machine generated from LSEG data November 8 at 09:03 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.49 -0.25 Beat
Jun. 30 2024 -0.54 -0.24 Beat
Mar. 31 2024 -0.76 -0.62 Beat
Dec. 31 2023 -0.62 -1.14 Missed